Stocks

The table gives an overview of all stocks, alphabetically sorted.
 DAEX DAX Apr 15, 2021 0.01 +5.58   
 DAOBet DAOC Apr 15, 2021 0.02 -1.00   
 DAOstack GENS Apr 15, 2021 0.30 -6.28   
 Dapp Token DAPPT Apr 15, 2021 0.01 -14.02   
 Darico DEC Apr 15, 2021 0.92 +5.58   
 DarkPayCoin D4RK Apr 15, 2021 0.08 -1.00   
 Datum DAT Apr 15, 2021 0.01 -0.98   
 Davinci Coin DAC Apr 15, 2021 0.01 +9.71   
 DDAM DDAM Apr 15, 2021 0.00 -0.03   
 DEAPCOIN DEP Apr 15, 2021 0.01 +5.32   
 Decent DCT Apr 15, 2021 0.04 +6.22   
 Decentraland MANA Apr 15, 2021 1.11 +1.28   
 Decentralized Vulnerability Platform DVP Apr 15, 2021 0.06 +1.14   
 Decred DCR Apr 15, 2021 206.58 +0.83   
 DeFiPie DPIE Apr 15, 2021 0.14 +38.75   
 Delphy DPY Apr 15, 2021 0.02 +6.67   
 Dero DERO Apr 15, 2021 3.96 +6.91   
 DEX DEX Apr 15, 2021 0.14 +5.58   
 DigiByte DGB Apr 15, 2021 0.11 +31.73   
 DigitalBits XDGB Apr 15, 2021 0.08 -2.07   
 DigitalCash DASH Apr 15, 2021 306.91 -1.11   
 DigitalNote XDN Apr 15, 2021 0.00 -0.98   
 Digitex Futures DGTX Apr 15, 2021 0.02 +18.16   
 district0x DNT Apr 15, 2021 0.31 +2.10   
 Ditcoin DIT Apr 15, 2021 0.00 +3.24   
 Divi Project DIVI Apr 15, 2021 0.05 +2.71   
 dKargo DKA Apr 15, 2021 0.25 +2.23   
 DMarket DMT Apr 15, 2021 1.30 +1.89   
 DMM: Governance DMG Apr 15, 2021 0.08 +1.30   
 DOCADEMIC MTC Apr 15, 2021 0.02 +2.68   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Data:


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK